Disseminated appendiceal mucinous tumors and the pseudomyxoma peritonei syndrome

CME Journal of Gynecologic Oncology

Volumn 8, Issue 2, 2003, Pages 204-211

  Sugarbaker, Paul H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

5 fluorouracil; Disseminated peritoneal adenomucinosis (DPAM); Intraperitoneal chemotherapy; Mitomycin C; Peritoneal carcinomatosis; Peritoneal mucinous carcinomatosis (PMCA); Peritonectomy procedures

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

APPENDIX TUMOR; CLINICAL FEATURE; CYTOREDUCTIVE SURGERY; DISEASE CLASSIFICATION; DISSEMINATED CANCER; DISSEMINATED MUCINOUS APPENDIX TUMOR; HISTOPATHOLOGY; HUMAN; MINIMAL RESIDUAL DISEASE; MORBIDITY; MORTALITY; PERITONEUM PSEUDOMYXOMA; QUANTITATIVE DIAGNOSIS; REVIEW; SCORING SYSTEM; STANDARDIZATION; SURGICAL TECHNIQUE;

EID: 0142166738     PISSN: 12199087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Werth P. Klinische und anatomische Untersuchungen zur Lehre von den Bauchgeschwuelsten und der Laparotomie. Arch Gynaekol 1884; 24:100.
2. Sebbag G, Shmookler BM, Chang D, Sugarbaker PH. Peritoneal carcinomatosis from an unknown primary site. Management of 15 patients. Tumori 2001; 87:67.
3. Carmignani P, Sugarbaker T, Bromley CM, Sugarbaker PH. Intraperitoneal cancer dissemination: Mechanisms of the patterns of spread. Metastases Rev (in press)
4. Ronnett BM, Yan H, Kurman RJ, et al. Pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis has a significantly more favorable prognosis than peritoneal mucinous carcinomatosis. Cancer 2001; 92(1):85.
5. Ronnett BM, Zahn CM, Kurman RJ, et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis: A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol 1995; 19(12):1390.
6. Yan H, Sugarbaker PH, Shmookler BM. Discordant histologic features between the primary appendiceal tumor and peritoneal surface implants in patients with mucinous malignancies of the appendix (abstract). Am J Clin Pathol 2001.
7. Sugarbaker PH, Ronnett BM, Archer A, et al. Pseudomyxoma peritonei syndrome. Adv Surg 1997; 30:233.
8. Fisher B, Fisher ER, Fedustea N. Trauma and localization of the tumor cells. Cancer 1967; 20:23.
9. Esquivel J, Sugarbaker PH. Clinical presentation of the pseudomyxoma peritonei syndrome. Br J Surg 2000; 87:1414.
10. Ronnett BM, Shmookler BM, Sugarbaker PH, Kurman RJ. Pseudomyxoma peritonei: New concepts in diagnosis, origin, nomenclature, relationship to mucinous borderline (low malignant potential) tumors of the ovary. Anatomic Pathology. ASCP Press, Chicago, 1997: 197.
11. Yan H, Pestieau SR, Shmookler BM, Sugarbaker PH. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: Failure vs. success with a second-look operation. Mod Pathol 2001; 14(3):164.
12. Gonzalez-Moreno S, Sugarbaker PH. Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. (Submitted)
13. Gough DB, Donohue JH, Schutt AJ, et al. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 1994; 219:112.
14. Esquivel J, Sugarbaker PH. Second-look surgery in patients with peritoneal dissemination of appendiceal malignancy. Analysis of prognostic factors in 98 patients. Ann Surg 2001; 234(2):198.
15. Mohamed F, Chang D, Sugarbaker PH. Third look surgery and beyond for appendiceal malignancy with peritoneal dissemination. J Surg Oncol 2003; 83:5.
16. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999; 6(8):727.
17. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995; 221(2):124.
18. Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the Coliseum technique. Ann Surg Oncol 1999; 6(8):790.